Coltene Holding AG operates within the Dental equipment and supplies sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Coltene Holding AG with three other
medical equipment manufacturers in Europe:
Stratec Biomedical AG
sales of 127.95 million Euro [US$163.41 million]
of which 104%
Consort Medical Plc
of the United Kingdom
(£101.36 million [US$165.62 million]
based in the United Kingdom
(£101.29 million [US$165.51 million]
of which 100%
was Retinal Equipment).
During the year ended December of 2013, sales at
Coltene Holding AG were 160.01 million Swiss Francs (US$169.32 million).
a very small
increase of 1.2%
versus 2012, when the company's sales were 158.08 million Swiss Francs.
The sales level in 2013 was fairly close to the level five years ago: in 2008, Coltene Holding AG had sales
of 166.42 million Swiss Francs.
Sales of Infection Control saw an increase
that was more than double the company's growth rate: sales were up
10.9% in 2013, from
10.82 million Swiss Francs to 11.99 million Swiss Francs.
Coltene Holding AG also saw significant increases in sales in
Restoration (up 4.9% to 44.88 million Swiss Francs)
Endodontics (up 2.5% to 30.16 million Swiss Francs)
Treatment Auxiliaries (up 8.1% to 17.00 million Swiss Francs)
Not all segments of Coltene Holding AG experienced an increase in sales in 2013:
sales of Rotary fell 4.2% to 10.91 million Swiss Francs.
Coltene Holding AG also experienced decreases in sales in
Laboratory (down 0.3% to 7.39 million Swiss Francs)